Safety and Immunogenicity Evaluation of the Malaria Vaccine, RTS,S/AS01, in Healthy Thai Adults
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; GSK 257049 (Primary) ; Primaquine (Primary)
- Indications Malaria
- Focus Adverse reactions; Pharmacodynamics
- 09 Aug 2017 Status changed from not yet recruiting to active, no longer recruiting, according to a PATH media release.
- 07 Apr 2017 Planned initiation date changed from 1 Feb 2017 to 5 May 2017.
- 16 Dec 2016 New trial record